Jane Huang
CIK 1683913 · President, CMO · last filed 2026-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$499.8K
Companies
3
Total Filings
73
Lifetime Open-Market Net
-$39.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 8
73 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-10 | TARA | Grant (A) | — | $0 | EDGAR |
| 2021-06-09 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −603 | -$212.0K | EDGAR |
| 2021-06-02 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | +7,189 | -$686.0K | EDGAR |
| 2021-05-03 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | — | -$488.2K | EDGAR |
| 2021-03-31 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | — | -$441.8K | EDGAR |
| 2021-03-02 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | — | -$436.9K | EDGAR |
| 2021-02-02 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | — | -$440.3K | EDGAR |
| 2020-12-30 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | — | -$329.5K | EDGAR |
| 2020-12-02 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | — | -$357.5K | EDGAR |
| 2020-11-02 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | — | -$405.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.